SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-17-053029
Filing Date
2017-10-18
Accepted
2017-10-18 16:16:54
Documents
1
Period of Report
2017-10-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv477168_4.html 4  
1 OWNERSHIP DOCUMENT tv477168_4.xml 4 5286
  Complete submission text file 0001144204-17-053029.txt   6898
Mailing Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087
Business Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087 610-254-4201
Aevi Genomic Medicine, Inc. (Issuer) CIK: 0001138776 (see all company filings)

IRS No.: 980217544 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O INTERCEPT PHARMACEUTICALS, INC. 18 DESBROSSES STREET NEW YORK NY 10013
Business Address
Duncan Barbara Gayle (Reporting) CIK: 0001353128 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35112 | Film No.: 171142778